Trisakti University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01463436
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Trisakti University

Active Ingredients

Drugs in Phase 3 Trials (1)

soybean (1 trial)

Drugs in Other Trials (1)

lactobacillus reuteri (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Osteoporosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2